Search Results Search Sort by RelevanceMost Recent Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711. Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394. Case and Commentary Jun 2021 How Should Clinicians Help Patients Navigate “Model Minority” Demands? Nellie Tran, PhD, Kevin Yabes, MS, and Arianne Miller, PhD The model minority myth has far-reaching implications for Asian Americans in many settings, including medicine. AMA J Ethics. 2021;23(6):E456-464. doi: 10.1001/amajethics.2021.456. Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465. Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514. Podcast May 2021 Ethics Talk: Public Health Messaging Design and Epidemic Management Drs Oliva Kates and Monica Gandhi join Ethics Talk to discuss equity and public health messaging in ending the HIV epidemic. Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519. Case and Commentary Jul 2021 When Imaging Data Contradict a Patient’s Self-report, How Should Clinicians Proceed? Joyeeta G. Dastidar, MD, MS, HEC-C Patients’ perceptions of how much input they have in making health decisions influence therapeutic alliance and outcomes. AMA J Ethics. 2021;23(7):E524-529. doi: 10.1001/amajethics.2021.524. Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711.
Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394.
Case and Commentary Jun 2021 How Should Clinicians Help Patients Navigate “Model Minority” Demands? Nellie Tran, PhD, Kevin Yabes, MS, and Arianne Miller, PhD The model minority myth has far-reaching implications for Asian Americans in many settings, including medicine. AMA J Ethics. 2021;23(6):E456-464. doi: 10.1001/amajethics.2021.456.
Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465.
Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514.
Podcast May 2021 Ethics Talk: Public Health Messaging Design and Epidemic Management Drs Oliva Kates and Monica Gandhi join Ethics Talk to discuss equity and public health messaging in ending the HIV epidemic.
Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519.
Case and Commentary Jul 2021 When Imaging Data Contradict a Patient’s Self-report, How Should Clinicians Proceed? Joyeeta G. Dastidar, MD, MS, HEC-C Patients’ perceptions of how much input they have in making health decisions influence therapeutic alliance and outcomes. AMA J Ethics. 2021;23(7):E524-529. doi: 10.1001/amajethics.2021.524.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.
Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537.